Cost-effectiveness and cost-utility of public place defibrillators in improving survival following pre-hospital cardiopulmonary arrest

Walker, A., Sirel, J., Marsden, A., Cobbe, S. and Pell, J. (2003) Cost-effectiveness and cost-utility of public place defibrillators in improving survival following pre-hospital cardiopulmonary arrest. British Medical Journal, 327(7427), p. 1316. (doi: 10.1136/bmj.327.7427.1316)

Full text not currently available from Enlighten.

Abstract

Objective: To determine the cost effectiveness and cost utility of locating defibrillators in all major airports, railway stations, and bus stations throughout Scotland. Design: Economic modelling exercise with data from Heartstart (Scotland). Parameters used in economic model included direct costs derived for increased accident and emergency attendances, increased hospital bed days, purchase and maintenance of defibrillators, and training in their use; life years gained calculated from increased discharges from hospital and mean survival after discharge; utility (quality of life) obtained from published data. Sensitivity analyses tested the robustness of model. Future gains discounted at 1.5% a year and future costs at 6%. Setting: Whole of Scotland. Subjects: Records of all prehospital cardiac arrests due to presumed heart disease that occurred in a major airport, railway, or bus station between May 1991 and March 1998 and were not witnessed by ambulance or medical staff. Main outcome measures: Observed survival to hospital admission and observed survival to discharge. Predicted survival calculated by applying observed survival in patients attended by ambulance staff within three minutes to those who waited longer. Results: The total discounted direct costs were £18 325 a year. The cost per life year gained was £29 625 ($49 625, €;43 151) and the cost per quality adjusted life year (QALY) gained was £41 146 ($68 924, €;59 932). More widespread provision of public place defibrillators would increase these figures. Conclusions: The cost per QALY calculated for public place defibrillators represents poorer value for money than some alternative strategies for improving survival after prehospital cardiopulmonary arrest, such as the use of other trained first responders. The figure exceeds the commonly discussed cut off levels for funding in the United Kingdom and United States of £30 000 and $50 000 per QALY, respectively.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Walker, Dr Andrew and Pell, Professor Jill and Cobbe, Professor Stuart
Authors: Walker, A., Sirel, J., Marsden, A., Cobbe, S., and Pell, J.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre
College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Public Health
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Centre for Population and Health Sciences
?? 20206000 ??
Journal Name:British Medical Journal
Journal Abbr.:BMJ
ISSN:0959-535X
ISSN (Online):1756-1833

University Staff: Request a correction | Enlighten Editors: Update this record